6Koizumi W, Kurihara M, Nakano S, et al. Phase II study of S-l,anovel oral derivative of 5-fluorouracil, in advanced gastric cancer.For the S-l Cooperative Gastric Cancer Study Group[ J]. Oncology,2000,58(3) :191 -197.
2Malet-Martino M,Martino R.Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine,UFT,S-1):a review[J].Oncologist,2002,7(4):288-323.
3Tanaka F,Fukuse T,Wada H,et al.The history,mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents[J].Curr Pharm Biotechnol,2000,1(2):137-164.
4Shirasaka T,Shimamato Y,Ohshimo H,et al.Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J].Anticancer Drugs,1996,7(5):548-557.
5Shirasaka T,Tsukuda M,Inuyama Y,et al.New oral anticancer drug,TS-1 (S-1)-from bench to clinic[J].Gan To Kagaku Ryoho,2001,28(6):855-864.
6Sato A,Ito T,Tomita T,et al.Chemotherapy of gastric cancer--a review of clinical trials in Japan[J].Gan To Kagaku Ryoho,2002,29(9):1522-1531.
7Shirasaka T. New oral anticancer drug, ( TS - 1 ) - from bench to clinic [J]. Gan To Kagaku Ryoho,2001.
8Koizumi W. S - 1 plus cisplatin versus S - 1 alone for first - line treatment of advanced gastric cancer ( SPIRITS trial) :a phase. Ⅲ trial[J]. Lancel Oncol,2008.
9Takahashi I. S - 1 in the treatment of advanced and recurrent gastric cancercurrent state and future prospects [ J ]. GASTRIC CANCER,2003.
10Boku N. Chemotherapy for metastatic disease:review from JCOG trials [ J ]. International Journal of Clinical Oncology ,2008.
1Imamura H, Kishimoto T,Takiuchi H,et al. Phase lI study of S- 1 monotherapy in patients over 75 years of age with advanced gastriccancer (OGSG0404) [ J ]. J Chemother, 2014, 26: 57-61.
2Xu R, Ma N, Wang F, et al. Resuhs of a randomized and con- trolled clinical trial evaluating the efficacy and safety of combi- nation therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer[J]. Onco Targets Ther, 2013, 6: 925-929.
3Price TJ, Shapiro JD, Segelov E, et al. Management of advanced gastric cancer[J]. Expert Rev Gastroenterol Hepatol, 2012, 6 : 199-208.
